Overview

A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.
Phase:
Phase 4
Details
Lead Sponsor:
Nordica Fertility Clinic
Collaborator:
Merck Serono International SA
Treatments:
Progesterone